Molecular analysis of the thiopurine S-methyltransferase alleles in Bolivians and Tibetans

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 5, 2005, Pages 491-496

  Lu, H F ^a,b,c   Shih, M C ^a   Hsueh, S C ^b   Chen, C M ^a   Chang, J Y ^a   Chang, Jan Gowth ^a,d,e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d Taipei Institute of Pathology   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

Bolivians; Polymerase chain reaction restriction fragment length polymorphism; Thiopurine S methyltransferase; Tibetans

Indexed keywords

GENOMIC DNA; THIOPURINE METHYLTRANSFERASE;

ARTICLE; BOLIVIA; CHINA; CONTROLLED STUDY; DNA EXTRACTION; DRUG ACTIVITY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; BOLIVIA; DNA; GENE FREQUENCY; HUMANS; METHYLTRANSFERASES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIBET;

EID: 27744602074     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2005.00640_1.x     Document Type: Article

References (33)

1. Johnson PJ, McFarlane IG, Williams R (1995) Azathioprine for long-term maintenance of remission in autoimmune hepatitis. New England Journal of Medicine, 333, 958-963.
2. Hollander AA, van Saase JL, Kootte AM et al. (1995) Beneficial effects of conversion from cyclosporine to azathioprine after kidney transplantation. Lancet, 345, 610-614.
3. Krynetski EY, Tai HL, Yates CR et al. (1996) Genetic polymorphism of thiopurine methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics, 6, 279-290.
4. Weinshiboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. American Journal of Human Genetics, 32, 651-662.
5. Remy CN (1963) Metabolism of thiopyrimidines and thiopurines: S-methylation with S-adenosylmethionine transmethylase and catabolism in mammalian tissues. Journal of Biological Chemistry, 238, 1078-1084.
6. Evans WE, Horner M, Chu YQ, Kalwinsky D, Roberts WM (1991) Altered mercaptopurine methyltransferase deficient child with acute lymphocytic leukemia. Journal of Pediatrics, 119, 985-989.
7. McLeod H, Lin JS, Scoot EP, Pui CH, Evans WE (1994) Thiopurine methyltransferase activity in American white subjects and black subjects. Clinical Pharmacology and therapeutics, 55, 15-20.
8. Otterness DM, Szumlanski CL, Lennard L et al. (1997) Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clinical Pharmacology and therapeutics, 62, 60-73.
9. Krynetski EY, Schuetz JD, Galpin AJ, Pui CH, Relling MV, Evans WE (1995) A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferae. Proceedings of the National Academy of Sciences of the United States of America, 92, 945-953.
10. Yates CR, Krynetski EY, Loennechen T et al. (1997) Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Annals of Internal Medicine, 126, 608-614.
11. Rossi AM, Bianchi M, Guarnieri C, Barale R, Pacifici GM (2001) Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. European Journal of Clinical Pharmacology, 57, 51-54.
12. Collie-Duguid ESR, Pritchard SC, Powrie RH et al. (1999) The frequency and distribution of thiopurine methyltransferase (TPMT) alleles in Caucasian and Asian populations. Pharmacogenetics, 9, 37-42.
13. Alves S, Prata MJ, Ferreira F, Amorim A (1999) Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern Portugal. Pharmacogenetics, 9, 257-261.
14. Ameyaw MM, Collie-Duguid DSR, Powrie RH, Ofori-Adkei D, McLeod HL (1999) Thiopurine methyltransferse alleles in British and Ghanaian populations. Human Molecular Genetics, 8, 367-370.
15. Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE (1999) Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Human Molecular Genetics, 8, 371-376.
16. Kumagai K, Hiyama K, Ishioka S et al. (2001) Allelo-type frequency of the thiopurine methyltransferase (TPMT) gene in Japanese. Pharmacogenetics, 11, 275-278.
17. Hongeng S, Sasanakul W, Chuansumrit A, Pakakasama S, Chattananon A, Hathirat P (2000) Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia. Medical and Pediatric Oncology, 35, 410-414.
18. Chang JG, Lee LS, Chen CM et al. (2002) Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations. Pharmacogenetics, 12, 191-195.
19. Srimartpirom S, Tassaneeyakul W, Kukongviriyapan V, Tassaneeyakul W (2004) Thiopurine S-methyltransferase genetic polymorphism in the Thai population. British Journal of Clinical Pharmacology, 58, 66-70.
20. Indjova D, Atanasova S, Shipkova M, Armstron VW, Oellerich M, Svinarov D (2003) Phenotypic and genetic analysis of thiopurine S-methyltransferase polymorphism in Bulgarian population. Therapeutic Drug Monitoring, 25, 631-636.
21. Marinaki AM, Arenas M, Khan ZH et al. (2003) Genetic determinants of the thiopurine methylatransferase intermediate activity phenotype in British Asians and Caucasians. Pharmacogenetics, 13, 97-105.
22. Zhang JP, Guan YY, Wu JH, Xu AL, Zhou S, Huang M (2004) Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups. British Journal of Clinical Pharmacology, 58, 163-168.
23. Reis M, Santoro A, Suarez-Kurtz G (2003) Thiopurine mehtyltransferase phenotypes and genotypes in Brazillians. Pharmacogenetics, 13, 371-373.
24. Schaeffeler E, Fischer C, Brockmeier D et al. (2004) Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics, 14, 407-117.
25. Chang JG, Chen PH, Chiou SS, Lee LS, Perng LL, Liu TC (1992) Rapid diagnosis of beta-thalassemia mutations in Chinese by naturally and amplified created restriction sites. Blood, 80, 2092-2096.
26. Honchel R, Aksoy IA, Seumlanski C et al. (1993) Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA. Molecular Pharmacology, 43, 878-887.
27. Szumlanski C, Otterness D, Her C et al. (1996) Thiopurine methyltransferase pharmacogenetics; human gene cloning and characterization of a common polymorphism. DNA and Cell Biology, 15, 17-30.
28. Thao HL, Krynetski EY, Yates CR et al. (1996) Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. American Journal of Human Genetics, 58, 694-702.
29. Otterness DM, Szumlanski CL, Wiid TC, Weinshilboum RM (1998) Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity. Journal of Clinical Investigation, 101, 1036-1044.
30. Black AJ, McLeod HL, Capell HA et al. (1998) Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Annals of Internal Medicine, 129, 716-718.
31. Ishioka S, Hiyama K, Sato H et al. (1999) Thiopurine methyltransferase genotype and toxicity of azathioprine in Japanese. Internal Medicine, 38, 944-947.
32. Corominas H, Domenech M, Laiz A et al. (2003) Is thiopurime methyltransferase genetic polymorphism a major factor for withdrawal of azathiopurine in rheumatoid arthritis patients? Rheumatology, 42, 40-45.
33. Marra CA, Esdaile JM, Anis AH (2002) Practical pharmacogenetics: the cost effectiveness of screening for thiopurine S-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. Journal of Rheumatology, 29, 2507-2512.